Envveno Medical

Envveno Medical company information, Employees & Contact Information

Explore related pages

Related company profiles:

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Company’s lead product, the VenoValve®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg. The VenoValve is currently being evaluated in the SAVVE pivotal study.

Company Details

Employees
29
Address
70 Doppler, Irvine,ca 92618,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Irvine, CA
Looking for a particular Envveno Medical employee's phone or email?

Envveno Medical Questions

News

Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency - Yahoo Finance

Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency Yahoo Finance

enVVeno Medical Faces Nasdaq Delisting Notice - TipRanks

enVVeno Medical Faces Nasdaq Delisting Notice TipRanks

US FDA deems Envveno’s VenoValve “not-approvable” - Venous News

US FDA deems Envveno’s VenoValve “not-approvable” Venous News

enVVeno tanks after FDA rejects VenoValve approval (NVNO:NASDAQ) - Seeking Alpha

enVVeno tanks after FDA rejects VenoValve approval (NVNO:NASDAQ) Seeking Alpha

Novel Venous Valve Device for 3.5M CVI Patients: enVVeno Challenges FDA Decision on VenoValve - Stock Titan

Novel Venous Valve Device for 3.5M CVI Patients: enVVeno Challenges FDA Decision on VenoValve Stock Titan

FDA denies PMA submission for enVVeno Medical’s VenoValve - MassDevice

FDA denies PMA submission for enVVeno Medical’s VenoValve MassDevice

enVVeno Medical Updates Regulatory Status of VenoValve(R) - Yahoo Finance

enVVeno Medical Updates Regulatory Status of VenoValve(R) Yahoo Finance

Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting - The Daily Jeffersonian

Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting The Daily Jeffersonian

enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - ACCESS Newswire

enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech ACCESS Newswire

EnVVeno Medical Names Jennifer Bright as CFO - Orange County Business Journal

EnVVeno Medical Names Jennifer Bright as CFO Orange County Business Journal

Inside enVVeno Medical: CEO Shares Breakthrough Vision for Deep Venous Disease Treatment Revolution - Stock Titan

Inside enVVeno Medical: CEO Shares Breakthrough Vision for Deep Venous Disease Treatment Revolution Stock Titan

enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) - Yahoo Finance

enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) Yahoo Finance

enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company - ACCESS Newswire

enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company ACCESS Newswire

EnVVeno has first-in-human valve data, expects FDA decision this year - MassDevice

EnVVeno has first-in-human valve data, expects FDA decision this year MassDevice

EnVVeno Medical receives Nasdaq notice for minimum bid price non-compliance - Investing.com

EnVVeno Medical receives Nasdaq notice for minimum bid price non-compliance Investing.com

FDA Rejects First-Ever Surgical Venous Valve Treatment: enVVeno's VenoValve Hits Regulatory Roadblock - Stock Titan

FDA Rejects First-Ever Surgical Venous Valve Treatment: enVVeno's VenoValve Hits Regulatory Roadblock Stock Titan

enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer - ACCESS Newswire

enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer ACCESS Newswire

enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment - Yahoo Finance

enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment Yahoo Finance

FDA Denies Approval of EnVVeno’s VenoValve - Medical Device and Diagnostic industry

FDA Denies Approval of EnVVeno’s VenoValve Medical Device and Diagnostic industry

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth - Yahoo Finance

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth Yahoo Finance

Medical Device Maker enVVeno Challenges FDA Rejection of Revolutionary Venous Valve Treatment - Stock Titan

Medical Device Maker enVVeno Challenges FDA Rejection of Revolutionary Venous Valve Treatment Stock Titan

enVVeno Medical stock plummets after FDA rejects VenoValve approval - Investing.com

enVVeno Medical stock plummets after FDA rejects VenoValve approval Investing.com

Why Is EnVVeno Medical Stock (NVNO) Down 70% Today? - TipRanks

Why Is EnVVeno Medical Stock (NVNO) Down 70% Today? TipRanks

enVVeno Medical Receives FDA Setback for VenoValve - TipRanks

enVVeno Medical Receives FDA Setback for VenoValve TipRanks

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth - simplywall.st

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth simplywall.st

enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering - Yahoo Finance

enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering Yahoo Finance

enVVeno Medical Shares Plunge 79% on FDA Denial - Orange County Business Journal

enVVeno Medical Shares Plunge 79% on FDA Denial Orange County Business Journal

Deep Venous Disease Treatment Pioneer enVVeno Medical to Showcase at Webull Biotech Conference - Stock Titan

Deep Venous Disease Treatment Pioneer enVVeno Medical to Showcase at Webull Biotech Conference Stock Titan

enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Newport Daily News

enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update Newport Daily News

enVVeno’s Roadblock Leaves Its Future Hanging On FDA Decisions - Finimize

enVVeno’s Roadblock Leaves Its Future Hanging On FDA Decisions Finimize

enVVeno: The Road To Approval Seems Open From Here On (NASDAQ:NVNO) - Seeking Alpha

enVVeno: The Road To Approval Seems Open From Here On (NASDAQ:NVNO) Seeking Alpha

Here's Why We're Not Too Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation - Yahoo Finance

Here's Why We're Not Too Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation Yahoo Finance

NVNO Stock Price and Chart — NASDAQ:NVNO - TradingView

NVNO Stock Price and Chart — NASDAQ:NVNO TradingView

enVVeno Medical Corporation Successfully Completes Rebranding - Stock Titan

enVVeno Medical Corporation Successfully Completes Rebranding Stock Titan

Top Envveno Medical Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant